Followers | 7 |
Posts | 1577 |
Boards Moderated | 0 |
Alias Born | 02/27/2014 |
Wednesday, April 29, 2015 1:57:06 PM
My expectation is that the company will sell for $170 to $195 million this year, with only q3 and q4 surpassing last year's revenue numbers.
The stock price will remain undervalued regardless....as there is no way it cannot break even and post minor profits with sales above $170 million per year, regardless of endorsements.
Revenues are under pressure because of protein spiking chatter, the complete lack of exciting and engaging communication and because BB.com is guiding traffic away from Musclepharm products towards Glanbia, Cellucor and new brands....hurting the growth in the short term.
The company has done a lot of right things, but lately it has gotten a little introvert and defensive in it's communication, which has made it drop a little bit in popularity among some customers and partners.
Right now, a realistic price target is $9.5....if Brad really delivered what was promised, hell the stock price would be $20....
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM